Dopexamine
- Generic Name
- Dopexamine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C22H32N2O2
- CAS Number
- 86197-47-9
- Unique Ingredient Identifier
- 398E7Z7JB5
- Background
Dopexamine has been used in trials studying the diagnostic and treatment of Free Flap, Oral Cancer, Hypotension, Septic Shock, and Head and Neck Cancer.
- Indication
用于需要舒张周围血管和肾血管患者的短期治疗，也用于心脏术后心力衰竭时增强收缩力的治疗。
- Associated Conditions
- -
- Associated Therapies
- -
Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-08-16
- Last Posted Date
- 2011-08-16
- Lead Sponsor
- Oxford University Hospitals NHS Trust
- Target Recruit Count
- 25
- Registration Number
- NCT01418118
- Locations
- 🇬🇧
John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath